SCHEMBL16440327

SCHEMBL16440327

CCn1nc(C#N)c2cc(Cl)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 2/20 0.42
▸ RAB9A P51151 1/20 0.40
▸ MAPT P10636 4/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ PTGER4 P35408 1/20 0.38
▸ ADORA2A P29274 1/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ CYP2A6 P11509 1/20 0.36
▸ MAT2A P31153 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876771 0.81 TSHR (0.43) MAPTTDP1CYP1A2CYP3A4CYP2C9
SCHEMBL19208377 0.80 MAPK8 (0.48) MAPK8MAPTCYP1A2CYP3A4CYP2C9
SCHEMBL16433339 0.80 RAB9A (0.42) MAPK8RAB9AMAPTCYP2A6KDM4E
SCHEMBL24182151 0.78 ADORA2A (0.62) MAPK8MAPTTDP1CYP1A2CYP3A4
SCHEMBL24316737 0.76 NOS3 (0.44) RAB9AMAPTL3MBTL1CYP2A6KDM4E
SCHEMBL19208697 0.76 MAPT (0.48) MAPK8MAPTKDM4EALDH1A1
SCHEMBL19236792 0.74 MAPT (0.47) MAPK8MAPTTDP1L3MBTL1KDM4E
SCHEMBL9043059 0.72 MAPK8 (0.53) MAPK8MAPTPTGER4KDM4EALDH1A1
SCHEMBL10095354 0.71 SMN1; SMN2 (0.50) RAB9ATDP1CYP2A6KDM4EALDH1A1
SCHEMBL11152305 0.71 ADORA2A (0.38) MAPK8RAB9AMAPTCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3027605-B1 NOVEL INDAZOLE COMPOUNDS AND A PROCESS FOR THE PREPARATION THEREOF COUNCIL SCIENT IND RES (IN) 2017-11-08 — — EP disclosed
US-9737510-B2 Indazole compounds and a process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2017-08-22 — — US disclosed
US-9737510-B2 Indazole compounds and a process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2017-08-22 — — US disclosed
US-20160185759-A1 NOVEL INDAZOLE COMPOUNDS AND A PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-06-30 — — US disclosed
US-20160185759-A1 NOVEL INDAZOLE COMPOUNDS AND A PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-06-30 — — US disclosed
WO-2015015519-A1 NOVEL INDAZOLE COMPOUNDS AND A PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-02-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185759-A1 NOVEL INDAZOLE COMPOUNDS AND A PROCESS FOR THE PREPARATION THEREOF GPR119, INSR, CYP11B1 MAPK8 1262/4885RAB9A 859/4885MAPT 2985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback